Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
about
Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools.Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cellsTautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumorsCombination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.MG-132 inhibits carcinoid growth and alters the neuroendocrine phenotype.Endocrine disturbances related to the use of lithium.Lithium improves survival of PC12 pheochromocytoma cells in high-density cultures and after exposure to toxic compounds.Nutritional limitation sensitizes mammalian cells to GSK-3β inhibitors and leads to growth impairment.A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.Inhibition of GSK-3β Activation Protects SD Rat Retina Against N-Methyl-N-Nitrosourea-Induced Degeneration by Modulating the Wnt/β-Catenin Signaling Pathway.
P2860
Q33363441-6BD6F575-0BF5-4D58-AF42-4351D8057EC0Q33411752-9D7318C8-5C5C-4B9C-A125-3CA3ED5D74A7Q33804934-C2F310C8-A857-405F-8FDC-52CDD28901B1Q34939579-752A21D9-A076-4D19-8137-448CA472012DQ37089077-AD33DEA9-C7C1-4440-A54F-16B71CE6A6F8Q37161813-CCD72A8A-70AD-4C22-8328-F3D55B131133Q37179117-CA4F16CA-4F9D-4A7D-A9B9-F4C91E067BF8Q37339815-420716CA-F6A4-4D1D-A1B5-115D6B946A46Q37480580-FBAAFB76-A202-433B-9499-E69271F8BE40Q38016176-15D00BF4-04FB-4A58-94B7-920C85EDD0F1Q39021456-28A88CB9-9353-4DC2-95F1-CAB9D0F39B4FQ39571150-12F8B400-A804-4B75-9D54-6A3CCFBB63DBQ39961844-0B0ABCAC-1EDF-460A-8774-3EAC293F05C9Q47656185-A59539C1-8EBB-40D3-9A18-5784C0524711
P2860
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
description
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/02/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/02/01)
@nl
наукова стаття, опублікована в лютому 2007
@uk
مقالة علمية (نشرت في فبراير 2007)
@ar
name
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@ast
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@en
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@nl
type
label
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@ast
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@en
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@nl
prefLabel
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@ast
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@en
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@nl
P2093
P2860
P1433
P1476
Lithium ions: a novel treatment for pheochromocytomas and paragangliomas
@en
P2093
Abram Vaccaro
Ashley Kappes
Herbert Chen
Muthusamy Kunnimalaiyaan
P2860
P304
161–165; discussion 165
P356
10.1016/J.SURG.2006.12.005
P407
P577
2007-02-01T00:00:00Z